Document is current
Any future updates will be listed below
-
Authors
Kinfe, Thomas M.
Asif, Maria
Chakravarthy, Krishnan V.
Deer, Timothy R.
Kramer, Jeffery M.
Yearwood, Thomas L.
Hurlemann, Rene
Hussain, Muhammad Sajid
Motameny, Susanne
Wagle, Prerana
Nürnberg, Peter
Gravius, Sascha
Randau, Thomas
Gravius, Nadine
Chaudhry, Shafqat R.
Muhammad, Sajjad
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00011267 at German Clinical Trials RegisterDocuments that mention this clinical trial
Unilateral L4-dorsal root ganglion stimulation evokes pain relief in chronic neuropathic postsurgical knee pain and changes of inflammatory markers: part II whole transcriptome profiling
https://doi.org/10.1186/s12967-019-1952-x
-
Funding
Funding for this research was provided by:
St. Jude Medical (Investigator-Initiated Trial)
- License Information
-
More Information
Article History
Received: 6 March 2019
Accepted: 9 June 2019
First Online: 19 June 2019
Ethical approval and consent to participate
: This study was performed according to the guidelines of the latest revision of the declaration of Helsinki. An independent internal local ethical research board/committee (IRB-No. 258/15) approved the study. The study was registered at the 15.11.2016 on German Register for Clinical Trials (DRKS ID 00011267). ExternalRef removed.
: All patients provided written informed consent.
: Thomas M. Kinfe has received training support and works as a consultant for Abbott (formerly St. Jude Medical, Inc.) and works as a consultant for Medtronic Inc. Sajjad Muhammad has received Neuromodulation and Pain Fellowship by Abbott Inc. (formerly St. Jude Medical). Jeff Kramer and Krishnan Chakravarthy works as a consultant to Abbott. Thomas L. Yearwood, MD, Ph.D. works as a consultant for St. Jude Medical, Boston Scientific Neuromodulation, Nevro Corp., and Neuronano; he is also the CMO of Meghan Medical.
